BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17198375)

  • 21. The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: implications for PKR autoregulation.
    Sharp TV; Moonan F; Romashko A; Joshi B; Barber GN; Jagus R
    Virology; 1998 Oct; 250(2):302-15. PubMed ID: 9792841
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner.
    Nallagatla SR; Bevilacqua PC
    RNA; 2008 Jun; 14(6):1201-13. PubMed ID: 18426922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. trans-Autophosphorylation by the isolated kinase domain is not sufficient for dimerization or activation of the dsRNA-activated protein kinase PKR.
    Wu S; Kaufman RJ
    Biochemistry; 2004 Aug; 43(34):11027-34. PubMed ID: 15323561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of RNA determinants recognized by the arginine- and proline-rich region of Us11, a herpes simplex virus type 1-encoded double-stranded RNA binding protein that prevents PKR activation.
    Khoo D; Perez C; Mohr I
    J Virol; 2002 Dec; 76(23):11971-81. PubMed ID: 12414939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unactivated PKR exists in an open conformation capable of binding nucleotides.
    Lemaire PA; Tessmer I; Craig R; Erie DA; Cole JL
    Biochemistry; 2006 Aug; 45(30):9074-84. PubMed ID: 16866353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition of viral RNA stem-loops by the tandem double-stranded RNA binding domains of PKR.
    Dzananovic E; Patel TR; Deo S; McEleney K; Stetefeld J; McKenna SA
    RNA; 2013 Mar; 19(3):333-44. PubMed ID: 23329698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biophysical and biochemical investigations of dsRNA-activated kinase PKR.
    McKenna SA; Lindhout DA; Shimoike T; Puglisi JD
    Methods Enzymol; 2007; 430():373-96. PubMed ID: 17913645
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular framework for the activation of RNA-dependent protein kinase.
    McKenna SA; Lindhout DA; Kim I; Liu CW; Gelev VM; Wagner G; Puglisi JD
    J Biol Chem; 2007 Apr; 282(15):11474-86. PubMed ID: 17284445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of double-stranded RNA to protein kinase PKR is required for dimerization and promotes critical autophosphorylation events in the activation loop.
    Zhang F; Romano PR; Nagamura-Inoue T; Tian B; Dever TE; Mathews MB; Ozato K; Hinnebusch AG
    J Biol Chem; 2001 Jul; 276(27):24946-58. PubMed ID: 11337501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NMR solution structure of a dsRNA binding domain from Drosophila staufen protein reveals homology to the N-terminal domain of ribosomal protein S5.
    Bycroft M; Grünert S; Murzin AG; Proctor M; St Johnston D
    EMBO J; 1995 Jul; 14(14):3563-71. PubMed ID: 7628456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The C-terminal, third conserved motif of the protein activator PACT plays an essential role in the activation of double-stranded-RNA-dependent protein kinase (PKR).
    Huang X; Hutchins B; Patel RC
    Biochem J; 2002 Aug; 366(Pt 1):175-86. PubMed ID: 11985496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of PKR: an open and shut case?
    Cole JL
    Trends Biochem Sci; 2007 Feb; 32(2):57-62. PubMed ID: 17196820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of the interactions between double-stranded RNA and the double-stranded RNA binding domain of the interferon induced protein kinase.
    Patel RC; Sen GC
    Cell Mol Biol Res; 1994; 40(7-8):671-82. PubMed ID: 7787885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Domain interactions in adenovirus VAI RNA mediate high-affinity PKR binding.
    Launer-Felty K; Cole JL
    J Mol Biol; 2014 Mar; 426(6):1285-95. PubMed ID: 24394721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variola virus E3L Zα domain, but not its Z-DNA binding activity, is required for PKR inhibition.
    Thakur M; Seo EJ; Dever TE
    RNA; 2014 Feb; 20(2):214-27. PubMed ID: 24335187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of PKR structure by small-angle scattering.
    VanOudenhove J; Anderson E; Krueger S; Cole JL
    J Mol Biol; 2009 Apr; 387(4):910-20. PubMed ID: 19232355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of the RNA-dependent protein kinase by triple helix formation.
    Vuyisich M; Beal PA
    Nucleic Acids Res; 2000 Jun; 28(12):2369-74. PubMed ID: 10871369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. RNA dimerization promotes PKR dimerization and activation.
    Heinicke LA; Wong CJ; Lary J; Nallagatla SR; Diegelman-Parente A; Zheng X; Cole JL; Bevilacqua PC
    J Mol Biol; 2009 Jul; 390(2):319-38. PubMed ID: 19445956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection of small-molecule mediators of the RNA regulation of PKR, the RNA-dependent protein kinase.
    Carlson CB; Spanggord RJ; Beal PA
    Chembiochem; 2002 Sep; 3(9):859-65. PubMed ID: 12210987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear factor 90 is a substrate and regulator of the eukaryotic initiation factor 2 kinase double-stranded RNA-activated protein kinase.
    Parker LM; Fierro-Monti I; Mathews MB
    J Biol Chem; 2001 Aug; 276(35):32522-30. PubMed ID: 11438540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.